VoCare Inc, Indianapolis, has developed a professional-grade medical diagnostic device that collects six different health vitals and is equipped with WiFi, Bluetooth, and 4G LTE for data transmission without the need for separate peripherals or an external hub.
Comparable in size to a cell phone, the Vitals360 device is the first telehealth instrument that can be used for both point-of-care and remote patient monitoring. The VoCare platform leverages a single connected device to empower management of multiple chronic conditions, including chronic obstructive pulmonary disease, congestive heart failure, diabetes, and hypertension. The Vitals360 device captures vital measurements of blood glucose, blood pressure, electrocardiography, oximetry, pulse, and temperature.
VoCare is in the process of obtaining its CE mark and FDA premarket notification (510(k)) clearance, and is on track for commercial launch in the coming months.
The VoCare Vitals360 runs on the Android operating system and is powered by Qualcomm chipsets, enabling the device to be used with virtually any wireless carrier worldwide. Moreover, the Vitals360 can be utilized with numerous backend solutions.
Steven R. Peabody, VoCare.
“We are looking forward to helping providers reduce healthcare costs, as well as ensuring better outcomes for their exploding chronically ill patient population,” says Steven R. Peabody, chief executive of VoCare.
For more information, visit VoCare.
